2023 Trends in Drug Benefit Design Report Webinar
Special Thanks to Our Sponsor:
Plan sponsors face complex decisions and challenges as they build and implement their drug benefit. PSG’s 2023 Trends in Drug Benefit Design Report provides a view into how plans work to achieve access and affordability for members while controlling their pharmacy spend.
Sponsored by Rx Savings Solutions, the report is chockful of helpful takeaways featuring insights from 180 benefits leaders representing plans across the country.
5 Key Takeaways
Here’s a sneak peek into a few of the key findings
Weight Loss Medications
With respondents divided on weight loss as a lifestyle or chronic condition, 43% cover FDA-approved weight loss medications, and 28% may in the next 1-2 years.
Utilization Management Programs
Growing percentages of respondents cite cost and cumbersomeness as barriers to utilization management programs.
Cost Sharing
The promotion of cost-sharing transparency tools to help members manage expenses continues to rise, from 28% in 2018 to 63% in 2023.
Formulary Management
A little over half of plans (53%) take steps to identify and reduce wasteful spend in the formulary.
Gene Therapy Financial Protection Products
Most (91%) respondents have heard of gene therapy financial protection products.
Download the Report
Expert insight from our panelists:
Renee Rayburg, RPh
VP, Clinical Strategy
Morgan Lee, PhD, MPH, CPH
Senior Director – Research & Strategy
Michael Medel, PharmD, MBA
Senior Vice President and Practice Lead – Plan Sponsors
Rebekah Gregg, MBA
Chief Operations Officer